Department of Otorhinolaryngology, Head and Neck Surgery, First Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Lasers Surg Med. 2020 Apr;52(4):333-340. doi: 10.1002/lsm.23143. Epub 2019 Aug 6.
Transoral laser surgery is the optimal surgical treatment modality for the early stages of glottic cancer. To allow for further treatment to be as effective and as minimal as possible, persistent or recurrent tumors should be detected very soon. The main aim is to minimize the risk of necessity of performing a total laryngectomy. Flexible videoendoscopy with narrow band imaging (NBI) was recommended by the European Laryngological Society as a diagnostic method for the follow-up of patients treated for laryngeal cancer. Nevertheless, the efficacy of this technique has not been extensively studied in patients after transoral laser cordectomies for vocal fold cancer. The aim of this study was to evaluate the efficacy of in-office transnasal NBI flexible videoendoscopy in the follow-up of patients after transoral laser cordectomy for glottic cancer. We also focused on describing the specific characteristics of recurrent tumor appearance.
The presented study was conceived as a prospective study. Ninety-four consecutive patients who underwent transoral laser cordectomy for severe dysplasia, Tis, T1, and T2 glottic cancer in the period from June 2010 to August 2015 were enrolled in the study. All patients were postoperatively regularly followed using transnasal videoendoscopic examinations with NBI. Whenever a suspect lesion was identified during in-office examination, its nature was proven histologically.
We discovered 23 suspect findings in 21 patients by means of flexible videoendoscopy with NBI. Fifteen (65.2%) of them were histologically confirmed as recurrent tumors, whereas in 8 (34.8%) of them, the recurrent tumor was not proven. In two patients, the recurrent tumor was evident on computed tomography or magnetic resonance imaging, but NBI endoscopy did not reveal relapsing disease. The rest (71 patients) were considered true negative. Of the 15 recurrent tumors detected by NBI-coupled videoendoscopy, 8 (53.3%) were identified as submucosal masses with nonsignificant or no vascular changes, 4 (26.7%) were noted as the progression of leukoplakia without visible vascular changes, only 2 (13.3%) showed typical vascular changes, and, in 1 (6.7%) case, evident, significantly exophytic tumor with pathological vascularization was discovered. The sensitivity, specificity, and positive and negative predictive values of the in-office transnasal videolaryngoscopy with NBI were calculated to be 88%, 92%, 71%, and 97%, respectively.
The results of the study demonstrate that transnasal endoscopy with NBI in an outpatient setting is an excellent method for the follow-up of patients after transoral laser cordectomy for glottic cancer. The method achieves high sensitivity, specificity, and negative predictive value and a slightly low positive predictive value. Nevertheless, we must bear in mind that recurrent tumors after previous endoscopic resection may have a completely different appearance than new tumors originating from previously untreated tissues. Lasers Surg. Med. © 2019 Wiley Periodicals, Inc.
经口激光手术是治疗早期声门癌的最佳手术治疗方式。为了使进一步的治疗尽可能有效和最小化,应尽快发现持续性或复发性肿瘤。其主要目的是最大限度地降低需要进行全喉切除术的风险。欧洲喉科学会推荐使用带窄带成像(NBI)的软性视频内镜检查作为喉癌患者随访的诊断方法。然而,在接受经口激光声带切除术治疗声带癌的患者中,该技术的疗效尚未得到广泛研究。本研究旨在评估经鼻 NBI 软性视频内镜在经口激光声带切除术治疗声门癌患者随访中的疗效。我们还专注于描述复发性肿瘤出现的具体特征。
本研究设计为前瞻性研究。2010 年 6 月至 2015 年 8 月期间,94 例接受经口激光声带切除术治疗严重发育不良、Tis、T1 和 T2 声门癌的连续患者纳入本研究。所有患者术后均定期接受经鼻视频内镜 NBI 检查。在门诊检查中发现可疑病变时,通过组织学证实其性质。
通过带 NBI 的软性视频内镜,我们在 21 例患者中发现了 23 个可疑病变。其中 15 例(65.2%)经组织学证实为复发性肿瘤,8 例(34.8%)未证实为复发性肿瘤。在 2 例患者中,复发性肿瘤在计算机断层扫描或磁共振成像上可见,但 NBI 内镜未发现疾病复发。其余(71 例)被认为是真正的阴性。在通过 NBI 联合视频内镜检测到的 15 个复发性肿瘤中,8 个(53.3%)被确定为黏膜下肿块,血管变化不明显或无变化,4 个(26.7%)为无明显血管变化的白斑进展,仅 2 个(13.3%)显示典型的血管变化,1 个(6.7%)病例发现明显外生性肿瘤,伴有病理性血管化。经鼻视频喉镜联合 NBI 的灵敏度、特异性、阳性和阴性预测值分别计算为 88%、92%、71%和 97%。
研究结果表明,经鼻内镜联合 NBI 检查是一种用于经口激光声带切除术治疗声门癌患者随访的极好方法。该方法具有较高的灵敏度、特异性和阴性预测值,以及略低的阳性预测值。然而,我们必须记住,先前内镜切除后的复发性肿瘤可能与源自先前未经治疗组织的新肿瘤具有完全不同的外观。